Oncotarget Trending With Impact: Unconventional Method Effectively Targets NSCLC In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more September 30, 2021
Oncotarget Trending With Impact: Promising Non-Small Cell Lung Cancer Prodrug Researchers examined the preclinical prodrug LP-184 and its efficacy in treating non-small cell lung cancers... read more August 26, 2021
Oncotarget Behind the Study: Retaining Nanomolar Potency in Lung Cancer Dr. Aditya Kulkarni discusses a study he co-authored, published by Oncotarget in 2021, and entitled, “... read more August 16, 2021
Oncotarget Behind the Study: miRNA-185 Emerges as Regulator of KRAS Harvard Medical School Professor Frank Slack discusses his 2016 study published in Oncotarget, entitled, “Cis-acting... read more April 18, 2021
Oncotarget Trending with Impact: Machine Learning Used to Compare ALK Inhibitors Researchers use a computer simulated modeling system to highlight the strengths and weaknesses of two... read more March 4, 2021
Oncotarget Behind the Study: Cancer Stem Cells and Macrophages Dr. Beatrice Aramini and Dr. Valentina Masciale provide an overview of their cancer research published... read more February 22, 2021
Oncotarget Trending with Impact: Novel MicroRNA Underexpressed in Lung Cancer In search of new ways to target lung cancer cells, researchers in this study demonstrated... read more February 4, 2021
Oncotarget Behind the Study: Targeting Stem Cells in Non-Small Cell Lung Cancer Researchers discuss their paper published in Oncotarget, entitled: "CD44+/EPCAM+ cells detect a subpopulation of... read more December 28, 2020
Oncotarget Trending with Impact: HIV Drug Repurposed to Treat Lung Cancer Researchers based out of South Africa published a new study of a drug most commonly... read more October 13, 2020